تداخل‌های دارویی
Alogliptin-pioglitazone + Daprodustat
شدت: متوسط
Alogliptin-pioglitazone and Daprodustat: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Pioglitazone is a weak CYP2C8 inhibitor, whereas daprodustat is a CYP2C8 substrate whose exposure rises with strong inhibitors such as gemfibrozil. A modest increase in daprodustat levels is possible, which could increase hemoglobin and thrombotic risk.
معنای این تداخل به زبان ساده
Alogliptin-pioglitazone and Daprodustat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Alogliptin-pioglitazone belongs to Endocrine; Daprodustat belongs to Endocrine.
چرا رخ می‌دهد
Inhibition of CYP2C8-mediated daprodustat metabolism.
اقدام لازم
Monitor hemoglobin and adjust the daprodustat dose accordingly when pioglitazone is started or stopped.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alogliptin-pioglitazone و Daprodustat، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Alogliptin-pioglitazone
تداخلات دیگر Daprodustat
پرسش‌های متداول
Can I take Alogliptin-pioglitazone with Daprodustat?
MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Daprodustat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pioglitazone is a weak CYP2C8 inhibitor, whereas daprodustat is a CYP2C8 substrate whose exposure rises with strong inhibitors such as gemfibrozil. A modest increase in daprodustat levels is possible, which could increase hemoglobin and thrombotic risk.
How serious is the interaction between Alogliptin-pioglitazone and Daprodustat?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor hemoglobin and adjust the daprodustat dose accordingly when pioglitazone is started or stopped.
What other medicines interact with Alogliptin-pioglitazone?
MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
